We are live on
!
Find out more
CBIO
Crescent Biopharma
CBIO
CBIO
50 hedge funds and large institutions have $115M invested in Crescent Biopharma in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
143% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 7
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
4% more funds holding
Funds holding: 48 → 50 (+2)
0.82% more ownership
Funds ownership: 0% → 0.82% (+0.82%)
12% less capital invested
Capital invested by funds: $131M → $115M (-$15.9M)
Holders
50
Holders Change
+2
Holders Change %
+4.17%
% of All Funds
1.25%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
17
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$2.5M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$475K |
| 3 |
Millennium Management
New York
|
+$317K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$231K |
| 5 |
Morgan Stanley
New York
|
+$205K |
